Orthopedic companies are using AI to enhance implant functionality, performance and longevity. The technology can optimize 3D computational designs, providing engineers with power to make faster, more informed decisions. In this panel discussion, R&D leaders share ways they leverage data-driven insights to inform design iteration and integrate AI-enhanced tools into workflows to create next-generation implants, models and apps that deliver on promises of improved patient care.
Brianna Prindle has played a pivotal role in the growth and success of restor3d, including its acquisitions of Kinos Medical and Conformis. As Director of Regulatory Affairs, Brianna has helped the company secure multiple 510(k) clearances, an HDE approval and various breakthrough device designations. Additionally, she leads post-market surveillance and sustaining regulatory efforts for the U.S., U.K. and EU markets. She has a B.S. in Biomedical Engineering from Georgia Institute of Technology. Her career began in R&D and quality engineering, providing essential experience in the total product lifecycle.
Jason Haider is the Founder and CEO of Xenco Medical, leading the company’s efforts in developing a breakthrough portfolio of biomimetic implants, regenerative biomaterials and polymer surgical instruments that are amplified in impact by groundbreaking software technologies from post-surgical remote therapeutic monitoring to preoperative holographic surgical simulation. Under Jason’s leadership, Xenco Medical has introduced a new category of surgical implant systems with its sterile-packaged spinal implants pre-attached to disposable, composite polymer delivery instruments. In recognition of its innovation and scale of distribution, Xenco Medical was named one of the World’s Most Innovative Companies by Fast Company in 2025 and 2023.
Martin D. Jaere, M.D., M.A., M.Sc., is a key contributor to advancements in medical imaging and computational anatomy. He holds dual master’s degrees in Innovation Design Engineering from the Royal College of Art and Imperial College London. His academic work has led to several scientific publications in orthopaedic surgery, image analysis and patient-specific instruments. In 2021, he joined Axial3D to help build scalable cloud solutions for personalized healthcare. He serves as the company’s Patient Specific Instrument Lead and is passionate about innovation, technology and user-centered design that can lead to better patient outcomes. His interdisciplinary background allows him to bridge clinical practice and engineering to deliver impactful solutions in healthcare technology.
Michael Evers is a Senior Market Analyst and writer at ORTHOWORLD. He leads the development of ORTHOWORLD’s proprietary revenue models, covers industry trends and co-authors THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT. Before joining ORTHOWORLD in 2018, Mr. Evers served in analyst roles within the cardiac rhythm management and physician practice management industries.
